Rachel L. Dittmar - Concepedia

Author

Rachel L. Dittmar

Medical College of Wisconsin ORCID

Also Known As

Dittmar, Rachel L, Rachel Dittmar, Rachel L Dittmar, Rachel L. Dittmar, Rachel Louise Dittmar

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Medical College of Wisconsin Mayo Clinic in Arizona Tongji Hospital Huazhong University of Science and Technology Mayo Clinic

About

Rachel L. Dittmar is an author at Medical College of Wisconsin specializing in medicine, pathology, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	854
2	Health Sciences	2	2	100
3	Natural Sciences	1	1	61
4	Cell Biology	1	1	61
5	Molecular Biology	1	1	61

Rachel L. Dittmar

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Characterization of human plasma-derived exosomal RNAs by deep sequencing Xiaoyi Huang, Tiezheng Yuan, Michael Tschannen, BMC Genomics	2013	1.1K
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer Xiaoyi Huang, Tiezheng Yuan, Meihua Liang, European Urology Prognostic BiomarkersUrologyOncologyGenitourinary CancerPrognostic Markers	2014	693
Plasma extracellular RNA profiles in healthy and cancer patients Tiezheng Yuan, Xiaoyi Huang, Mark G. Woodcock, Scientific Reports	2016	285
Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome Meijun Du, Tiezheng Yuan, Kala F. Schilter, Human Molecular Genetics GeneticsGenetic EpidemiologyGenomic MechanismMolecular BiologyGene Characterization	2014	61
Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer Yun Xia, Chiang‐Ching Huang, Rachel L. Dittmar, Oncotarget BioinformaticsAr AmplificationUrologyOncologyUrine Cfdnas	2016	58
Cell‐free <scp>DNA</scp> copy number variations in plasma from colorectal cancer patients Jian Li, Rachel L. Dittmar, Shu Xia, Molecular Oncology	2017	54
Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls Shu Xia, Chiang‐Ching Huang, Min Le, Lung Cancer Normal ControlsOncologyTumor HeterogeneityMedicineOncogenic Agent	2015	42
Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer Shu Xia, Manish Kohli, Meijun Du, Oncotarget	2015	42
Chromatin interactions and candidate genes at ten prostate cancer risk loci Meijun Du, Lori S. Tillmans, Jianzhong Gao, Scientific Reports	2016	42
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer Rachel L. Dittmar, Suyu Liu, Mei-Chee Tai, Cancer Prevention Research	2021	32

Page 1